No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis

Multiple Sclerosis Journal

Volumn 20, Issue 12, 2014, Pages 1670-1671

  Runia, Tessel F ^a   Van Meurs, Marjan ^a   Nasserinejad, Kazem ^a   Hintzen, Rogier Q ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; LETTER; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; REMISSION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; PROSPECTIVE STUDY; RECURRENCE RISK; BLOOD; FEMALE; MALE;

FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; OSTEOPONTIN;

EID: 84910115061     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514528765     Document Type: Letter

References (3)

1. Kivisakk P, Healy BC, Francois K, et al. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Mult Scler. 2013 ;:
2. Steinman L. A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol. 2009 ; 9: 440-447
3. Vogt MH, Floris S, Killestein J, et al. Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients. J Neuroimmunol. 2004 ; 155: 155-160